Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

New approaches to personalised medicine

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.05.12
Views: 2787
Rating:

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany

Prof Jens Ricke talks to ecancer about the need to move away from pharmaceutically funded approaches to personalised medicine at the European Forum on Oncology in Berlin, May 2012.

 

Personalised medicine is an individual treatment for an individual patient’s unique disease. However, current clinical trials funded by pharmaceutical companies do not result in such treatments. Prof Ricke suggests selecting doctors from a large group of specialists to develop an individual plan for each patient.

 

Related videos

follow us

CML Life Banner


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation